Drug Shortage Report for SUPREFACT DEPOT 3 MONTHS
Report ID | 207981 |
Drug Identification Number | 02240749 |
Brand name | SUPREFACT DEPOT 3 MONTHS |
Common or Proper name | Buserelin acetate implant |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | BUSERELIN |
Strength(s) | 9.45MG |
Dosage form(s) | IMPLANT |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 1 applicator |
ATC code | L02AE |
ATC description | HORMONES AND RELATED AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-10-24 |
Estimated end date | |
Actual end date | 2024-05-16 |
Shortage status | Resolved |
Updated date | 2024-05-17 |
Company comments | The product will be discontinued due to manufacturing issues |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-05-17 | English | Compare |
v5 | 2024-05-16 | French | Compare |
v4 | 2024-05-16 | English | Compare |
v3 | 2023-10-25 | English | Compare |
v2 | 2023-10-24 | French | Compare |
v1 | 2023-10-24 | English | Compare |
Showing 1 to 6 of 6